Board of Directors

The Executive Board works on a voluntary basis. It manages the business of the association and is responsible for all matters that are not assigned to the General Assembly.

Members of the Executive Board 2023-2025

Dr. Paul Hadrossek

Chairman

Dr. Paul Hadrossek supports companies with innovation strategies, advises investors on investment issues, their portfolio companies and start-ups. Prior to this, he worked as a research assistant and senior physician at Münster University Hospital and set up a dental care center. The establishment of a company builder for the healthcare sector and, as a result, the founding of the telemedicine company Kinderheldin in 2017 were important milestones for him. With Kinderheldin, he was part of the SVDGV founding companies to jointly enable digital healthcare solutions to find a sustainable way into healthcare. Dr. Paul Hadrossek has been an elected member of the Board of Directors since 2020 and Chairman of the SVDGV Board of Directors since October 2023.

Dr. Anna Haas

1st Deputy Chairwoman of the Management Board

Dr. Anna Haas is Managing Director of Oviva Germany and also responsible for Oviva France. Oviva helps people with weight-related diseases through an accessible and effective therapy. Prior to Oviva, Dr. Anna Haas was Managing Director at Shire Pharmaceuticals in Ireland and Project Manager at McKinsey & Company in Europe and Asia. She studied biochemistry at the University of Potsdam and holds a doctorate in immunology from ETH Zurich.

Henrik Emmert

2. Vice Chairman of the Board

Henrik Emmert is co-founder and CEO of aidhere GmbH, a digital health company founded in 2019. The first product of aidhere GmbH is the digital obesity therapy “zanadio”. In November 2020, the programme was one of the first applications to be approved by the Federal Institute for Drugs and Medical Devices as a Digital Health Application (DiHA) and included in the list of prescribable products.
Previously, the industrial engineer was a principal at the Boston Consulting Group, advising international companies in the healthcare sector.

Markus C. Müller

Member of the Board & Treasurer

Markus C. Müller is CEO and co-founder of Nui Care, which is developing a digital platform for family caregivers. He studied law at LMU Munich and founded his first software company during his studies, which he sold to BlackBerry in 2011. He rose to the position of Head of Europe before leaving the company in 2015 and training as a volunteer end-of-life caregiver. This activity brought him into contact with the care sector and family caregivers. He founded Nui Care to help this group digitally.

Dr. Julian Braun

Member of the Board

Dr. iur. Julian Braun has been a member of the SVDGV Board since 2019 and is the association’s legal advisor. In this role, he deals with all health law issues within the SVDGV, is in charge of negotiating important industry framework agreements for the digital health industry (including the DiGA and DiPA framework agreements), prepares the association’s statements on draft legislation from the BMG, is a member of the joint DiGA body and regularly conducts arbitration negotiations for member companies. As General Counsel Medical Law at Ada Health GmbH, Julian Braun focuses on internationally emerging legal issues that affect Ada GmbH’s global business and play a role in the regulatory field of medical device software and artificial intelligence. In addition, advising on digital health and health insurance law issues is another focus of his work.

Anisa Idris

Board member

Anisa Idris joined the SVDGV in 2020 and deals with patent and reimbursement law issues. In this role, she also co-led the negotiation for 13 manufacturer associations in the DiGA Framework Agreement negotiation with Julian Braun.
With her team at Ada Health, Anisa works on global reimbursement strategies, taking into account medical device law issues. She has 15 years of experience in pharmaceutical management, including her previous role as Director for Digital Innovation & Performance, where she was responsible for the strategic direction of all digital activities of the individual Novartis Pharma national companies in the European region of Novartis Pharma AG and led the health care management contracting of Novartis Pharma in Germany.

Dr. med. Christoph Twesten

Member of the Board

Dr. med. Christoph Twesten is CTO and co-founder of the DiGA manufacturer Perfood GmbH. He brings his expertise to the association as head of the data protection working group and supports the SVDGV in shaping the data protection and security landscape for the DiGA ecosystem. He began his medical career by successfully completing his medical studies in 2012, after which he worked as a doctor of internal medicine at the University Medical Center Schleswig-Holstein in Lübeck from 2013 to 2017. In 2017, he co-founded the DiGA manufacturer “Perfood”(www.perfood.de), where he has since served as Chief Technology Officer. In this role, Dr. Twesten is not only responsible for technical progress and innovation; he also oversees the approval processes for medical devices and the implementation of artificial intelligence in the product development process. In addition to medicine, his professional spectrum also includes in-depth knowledge of software development, which he has gained from numerous software projects since childhood.